AI & Machine Learning
Learn how unparalleled data, domain expertise, and technologies enable AI-powered solutions that are purpose-built for healthcare.
-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Research & Development
-
Real World Evidence
-
Commercialization
-
Integrated Global Compliance
-
Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
- Information Partner Services
- Financial Institutions
- Public Health and Government
- Patient Associations
- Payers
- Providers
THERAPEUTIC AREAS
- Cardiovascular
- Cell and Gene Therapy
- Central Nervous System
- GI & Hepatology
- Infectious Diseases and Vaccines
- Oncology
- Pediatrics
- Rare Diseases
- View All
Harness the power to transform clinical development
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewResearch & Development Quick Links
Real World Evidence. Real Confidence. Real Results.
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWReal World Evidence Quick Links
See markets more clearly. Opportunities more often.
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWCommercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety and quality.
COMPLIANCE OVERVIEWIntegrated Global Compliance Quick Links
Intelligence that transforms life sciences end-to-end.
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWTechnology Quick Links
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
BLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSTHE IQVIA INSTITUTE
An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSFEATURED INNOVATIONS
-
Connected Intelligence
-
AI & Machine Learning
-
Human Data Science Cloud
-
IQVIA Innovation Hub
-
Decentralized Trials
-
Genomics
WHO WE ARE
- Our Story
- Commitment to Public Health
- Code of Conduct
- Environmental Social Governance
- Privacy
- Executive Team
NEWS & RESOURCES
Unlock your potential to drive healthcare forward
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
AI & Machine Learning with a healthcare IQ.
Artificial intelligence is accelerating opportunities. Realizing the benefits for healthcare requires the right expertise. Together, we can solve the problems of today, and drive the breakthroughs of tomorrow.
LEARN MORE
Your healthcare data deserves more than just a cloud.
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
Proven, faster DCT solutions
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
Unlock the power of genomic research.
IQVIA enables genomic research via global access to a network of genomic-clinical data, proprietary technologies that enable federated analytics, and therapeutic area & bioinformatics expertise to help you answer your most pressing research questions.
LEARN MOREWORKING AT IQVIA
Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORELIFE AT IQVIA
Careers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE
WE’RE HIRING
"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBS
White Paper
Putting Patient Perspectives at the heart of cancer care
Using Artificial Intelligence (AI) to generate new patient insights in breast cancer
Feb 09, 2018
Thanks to earlier diagnosis and improved treatment, cancer patients are living longer and healthier lives. However, cancer will present significant challenges in the years to come, and nowhere is this more apparent than in Asia.
Asia now accounts for half of the global burden of cancer, and the World Health Organization predicts that incidence will rise from 6.8 million cases in 2012 to 10.8 million in 2030. Incidence of breast cancer alone in Asia is predicted to increase from 651,000 cases in 2012 to 920,000 by 2030, constituting over a third of the global total.
This challenge has both a human and a financial dimension. Too many people will have their lives affected or cut short by cancer, and the costs of cancer will continue to grow. It is therefore vital that we target investment on the support, services and treatments which will make the biggest difference to patients, maximizing the value of cancer care.
It is impossible to do this without understanding the issues that cancer patients face, along with their needs and preferences. There are a range of different ways to capture the perspective of patients, ranging from surveys of experiences or quality of life, to advisory and focus groups. However, technological advances create opportunities to supplement these existing methods, drawing on the experiences and activities of large numbers of patients in their everyday lives.
This report documents the approach and findings of a pilot initiated by IQVIA which used an Artificial Intelligence (AI) platform to explore the key priorities and concerns of breast cancer patients in Singapore. The pilot analyzed online activity among the Singaporean population over the past two years, evaluating more than 46,000 unique online activity patterns to derive insights. It is estimated that these activities were generated by approximately 7,000 people affected by cancer.
This is the first AI study of its kind, breaking new ground in the field of value-based cancer care. The purpose of this report is to provide recommendations on how AI can be used by policymakers, as well as providers of cancer treatment and information services, to make decisions based on the real life needs and preferences of patients.
SUMMARY OF FINDINGS
The findings from the pilot confirm many of the quality of life issues established in the research literature and reaffirm the importance of tailoring support and services to individual patients. Breast cancer patients are not a homogenous group, and encounter specific needs and challenges that are unique to each stage.
Patients with early stage (1 and 2) breast cancer appear to seek further support with:- Advice on insurance and treatment costs
- Information on Emergency Department
- Enhanced information on side effects of treatment
- Advice about financial affairs
- Information on outpatient appointments and logistics such as car parking
- Enhanced information on pain management
- Support on managing family relationships
- Support on managing sleep
- Improved support on depression, stress and anxiety
- Information on treatments appropriate to stage
- Information on breast cancer and patient support groups
- Enhanced workplace support
- Information on appropriate physical activity
- Access to spiritual and religious support where this is requested